KK
JAZZ icon

KLP Kapitalforvaltning’s Jazz Pharmaceuticals JAZZ Stock Holding History

KLP Kapitalforvaltning’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.05M Buy
21,400
+900
+4% +$157K 0.02% 528
2025
Q4 		$3.48M Sell
20,500
-2,200
-10% -$337K 0.01% 556
2025
Q3 		$2.99M Sell
22,700
-1,100
-5% -$132K 0.01% 572
2025
Q2 		$2.53M Buy
23,800
+6,500
+38% +$706K 0.01% 588
2025
Q1 		$2.15M Buy
17,300
+300
+2% +$39.1K 0.01% 627
2024
Q4 		$2.09M Buy
+17,000
New +$2M 0.01% 650

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

KLP Kapitalforvaltning's JAZZ Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Jazz Pharmaceuticals (JAZZ) stake by 4.4% in Q1 2026, buying an estimated $157K and bringing the position to 21,400 shares worth $4.05M. The position accounts for 0.02% of the portfolio, ranked #528.

KLP Kapitalforvaltning first reported a position in JAZZ in Q4 2024 and has held it in 6 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • KLP Kapitalforvaltning held 21,400 shares of Jazz Pharmaceuticals worth $4.05M as of Q1 2026.
  • KLP Kapitalforvaltning bought 900 Jazz Pharmaceuticals shares in Q1 2026, an estimated $157K.
  • Jazz Pharmaceuticals made up 0.02% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #528 holding.
  • KLP Kapitalforvaltning first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.